UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 29

Sortiert nach

Characterization of binding, functional activity, and contractile responses of the selective 5‐HT1F receptor agonist lasmiditan

British journal of pharmacology, 2019-12, Vol.176 (24), p.4681-4695

2019

Volltextzugriff (PDF)

Migraine and cluster headache – the common link

Journal of headache and pain, 2018-09, Vol.19 (1), p.89-15, Article 89

2018

Volltextzugriff (PDF)

Triptans and CGRP blockade – impact on the cranial vasculature

Journal of headache and pain, 2017-10, Vol.18 (1), p.103-7, Article 103

2017

Volltextzugriff (PDF)

Lasmiditan inhibits calcitonin gene-related peptide release in the rodent trigeminovascular system

Pain (Amsterdam), 2020-05, Vol.161 (5), p.1092-1099

2020

Volltextzugriff (PDF)

Long COVID headache

Journal of headache and pain, 2022-08, Vol.23 (1), p.93-93, Article 93

2022

Volltextzugriff (PDF)

Pharmacological analysis of the increases in heart rate and diastolic blood pressure produced by (S)-isometheptene and (R)-isometheptene in pithed rats

Journal of headache and pain, 2017-12, Vol.18 (1), p.52-52, Article 52

2017

Volltextzugriff (PDF)

Sex differences in CGRP-induced vasodilation of human middle meningeal arteries but not human coronary arteries: implications for migraine

Cephalalgia, 2024-07, Vol.44 (7), p.3331024241254088

2024

Volltextzugriff (PDF)

Characterisation of vasodilatory responses in the presence of the CGRP receptor antibody erenumab in human isolated arteries

Cephalalgia, 2019-12, Vol.39 (14), p.1735-1744

2019

Volltextzugriff (PDF)

Exploration of purinergic receptors as potential anti-migraine targets using established pre-clinical migraine models

Cephalalgia, 2019-10, Vol.39 (11), p.1421-1434

2019

Volltextzugriff (PDF)

Trigeminovascular calcitonin gene-related peptide function in Cacna1a R192Q-mutated knock-in mice

Journal of cerebral blood flow and metabolism, 2019-04, Vol.39 (4), p.718-729

2019

Volltextzugriff (PDF)

Persistent post-traumatic headache: a migrainous loop or not? The clinical evidence

Journal of headache and pain, 2020-05, Vol.21 (1), p.55-55, Article 55

2020

Volltextzugriff (PDF)

Mode and site of action of therapies targeting CGRP signaling

Journal of headache and pain, 2023-09, Vol.24 (1), p.125-125, Article 125

2023

Volltextzugriff (PDF)

Persistent post-traumatic headache: a migrainous loop or not? The preclinical evidence

Journal of headache and pain, 2020-07, Vol.21 (1), p.90-90, Article 90

2020

Volltextzugriff (PDF)

Is selective 5-HT1F receptor agonism an entity apart from that of the triptans in antimigraine therapy?

Pharmacology & therapeutics (Oxford), 2018-06, Vol.186, p.88-97

2018

Volltextzugriff (PDF)

Gender aspects of CGRP in migraine

Cephalalgia, 2019-03, Vol.39 (3), p.435-444

2019

Volltextzugriff (PDF)

Calcitonin/PAC1 receptor splice variants: a blind spot in migraine research

Trends in pharmacological sciences (Regular ed.), 2023-10, Vol.44 (10), p.651-663

2023

Volltextzugriff (PDF)

Current understanding of meningeal and cerebral vascular function underlying migraine headache

Cephalalgia, 2019-11, Vol.39 (13), p.1606-1622

2019

Volltextzugriff (PDF)

Effects of two isometheptene enantiomers in isolated human blood vessels and rat middle meningeal artery – potential antimigraine efficacy

Journal of headache and pain, 2019-05, Vol.20 (1), p.47-47, Article 47

2019

Volltextzugriff (PDF)

Characterization of binding, functional activity, and contractile responses of the selective 5-HT 1F receptor agonist lasmiditan

British journal of pharmacology, 2019-12, Vol.176 (24), p.4681-4695

2019

Volltextzugriff (PDF)

Pharmacological analysis of the inhibition produced by moxonidine and agmatine on the vasodepressor sensory CGRPergic outflow in pithed rats

European journal of pharmacology, 2017-10, Vol.812, p.97-103

2017

Volltextzugriff (PDF)

Characterization of the trigeminovascular actions of several adenosine A2A receptor antagonists in an in vivo rat model of migraine

Journal of headache and pain, 2018-05, Vol.19 (1), p.1-10, Article 41

2018

Volltextzugriff (PDF)

Bridging the gaps of headache care for underserved populations: Current status of the headache field in Latin America

Cephalalgia, 2022-09, Vol.42 (10), p.1086-1090

2022

Volltextzugriff (PDF)

Health equity, care access and quality in headache – part 2

Journal of headache and pain, 2023-12, Vol.24 (1), p.167-167, Article 167

2023

Volltextzugriff (PDF)

Calcitonin/PAC 1 receptor splice variants: a blind spot in migraine research

Trends in pharmacological sciences (Regular ed.), 2023-08

2023

Volltextzugriff (PDF)

Is selective 5-HT 1F receptor agonism an entity apart from that of the triptans in antimigraine therapy?

Pharmacology & therapeutics (Oxford), 2018-06, Vol.186, p.88-97

2018

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(27)
Buchkapitel
(2)

Sprache

Englisch
(29)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Characterization of binding, functional activity, and contractile responses of the selective 5‐HT1F receptor agonist lasmiditan

Migraine and cluster headache – the common link

Triptans and CGRP blockade – impact on the cranial vasculature

Lasmiditan inhibits calcitonin gene-related peptide release in the rodent trigeminovascular system

Long COVID headache

Pharmacological analysis of the increases in heart rate and diastolic blood pressure produced by (S)-isometheptene and (R)-isometheptene in pithed rats

Sex differences in CGRP-induced vasodilation of human middle meningeal arteries but not human coronary arteries: implications for migraine

Characterisation of vasodilatory responses in the presence of the CGRP receptor antibody erenumab in human isolated arteries

Exploration of purinergic receptors as potential anti-migraine targets using established pre-clinical migraine models

Trigeminovascular calcitonin gene-related peptide function in Cacna1a R192Q-mutated knock-in mice

Persistent post-traumatic headache: a migrainous loop or not? The clinical evidence

Mode and site of action of therapies targeting CGRP signaling

Persistent post-traumatic headache: a migrainous loop or not? The preclinical evidence

Is selective 5-HT1F receptor agonism an entity apart from that of the triptans in antimigraine therapy?

Gender aspects of CGRP in migraine

Calcitonin/PAC1 receptor splice variants: a blind spot in migraine research

Current understanding of meningeal and cerebral vascular function underlying migraine headache

Effects of two isometheptene enantiomers in isolated human blood vessels and rat middle meningeal artery – potential antimigraine efficacy

Characterization of binding, functional activity, and contractile responses of the selective 5-HT 1F receptor agonist lasmiditan

Pharmacological analysis of the inhibition produced by moxonidine and agmatine on the vasodepressor sensory CGRPergic outflow in pithed rats

Characterization of the trigeminovascular actions of several adenosine A2A receptor antagonists in an in vivo rat model of migraine

Bridging the gaps of headache care for underserved populations: Current status of the headache field in Latin America

Health equity, care access and quality in headache – part 2

Calcitonin/PAC 1 receptor splice variants: a blind spot in migraine research

Is selective 5-HT 1F receptor agonism an entity apart from that of the triptans in antimigraine therapy?

Suchergebnisse filtern